Allogene Therapeutics Inc...

1.38
-0.06 (-4.17%)
At close: Apr 03, 2025, 3:59 PM
1.37
-0.72%
Pre-market: Apr 04, 2025, 04:51 AM EDT

Allogene Therapeutics Revenue

Allogene Therapeutics reported an annual revenue of $22K, reflecting a -76.84% growth. For the quarter ending December 31, 2024, Allogene Therapeutics generated $0 in revenue.
Revenue (ttm)
$22K
Revenue Growth
-76.84%
Price / Sales Ratio
18861.32
Revenue / Employee
$97.35
Employees
226
Market Cap
299.83M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 22K -76.84%
Dec 31, 2023 95K -60.91%
Dec 31, 2022 243K -99.37%
Dec 31, 2021 38.49M +Infinity%
Dec 31, 2020 0 n/a